UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A prospective, placebo-controlled study of the luteinizing hormone-releasing hormone agonist leuprolide as treatment for patients with benign prostatic hyperplasia

The Journal of urology, 1993-08, Vol.150 (2 Pt 1), p.359-364

1993

Volltextzugriff (PDF)

A prospective, placebo-controlled study of the antiandrogen Casodex as treatment for patients with benign prostatic hyperplasia

The Journal of urology, 1993-07, Vol.150 (1), p.90-94

1993

Volltextzugriff (PDF)

Pathologic Downstaging Is a Surrogate Marker for Efficacy and Increased Survival Following Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Urothelial Bladder Cancer

European urology, 2012-06, Vol.61 (6), p.1229-1238

2012

Volltextzugriff (PDF)

Safety, side effects and patient acceptance of the luteinizing hormone releasing hormone agonist leuprolide in treatment of benign prostatic hyperplasia

The Journal of urology, 1994-08, Vol.152 (2 Pt 1), p.448-452

1994

Volltextzugriff (PDF)

Effects of bicalutamide and leuprolide on prostate-specific antigen (PSA), acid phosphatase (ACP) and prostatic acid phosphatase (PAP) in men with benign prostatic hyperplasia (BPH)

Prostate cancer and prostatic diseases, 2001-01, Vol.4 (3), p.173-177

2001

Volltextzugriff (PDF)

Safety, side effects and patient acceptance of the antiandrogen Casodex in the treatment of benign prostatic hyperplasia

European urology, 1994-01, Vol.26 (3), p.219-226

1994

Volltextzugriff (PDF)

alpha-blockade in the treatment of symptomatic benign prostatic hyperplasia

The Journal of urology, 1995-09, Vol.154 (3), p.923-934

1995

Volltextzugriff (PDF)

Measuring the quality of life of patients with benign prostatic hyperplasia. Assessment of the usefulness of a new quality of life questionnaire specially adapted to benign prostatic hyperplasia patients

European urology, 1992, Vol.21 (4), p.257

1992

Volltextzugriff (PDF)

Treatment of benign prostatic hyperplasia : A pharmacoeconomic perspective

Drugs & aging, 1997-02, Vol.10 (2), p.107-118

1997

Volltextzugriff (PDF)

Histopathological grading and DNA ploidy as prognostic markers in metastatic prostatic cancer

British journal of cancer, 1995-05, Vol.71 (5), p.1055-1060

1995

Volltextzugriff (PDF)

Extent of disease based on initial bone scan: important prognostic predictor for patients with metastatic prostatic cancer. Experience from the Scandinavian Prostatic Cancer Group Study No. 2 (SPCG-2)

European urology, 1995, Vol.28 (1), p.40

1995

Volltextzugriff (PDF)

Patient recruitment to and cost of a prospective trial of medical treatment for benign prostatic hyperplasia

European urology, 1992, Vol.22 (1), p.9

1992

Volltextzugriff (PDF)

Effects on the endocrine system of long-term treatment with the luteinizing hormone-releasing hormone agonist leuprolide in patients with benign prostatic hyperplasia

Scandinavian journal of clinical and laboratory investigation, 1996, Vol.56 (4), p.319-325

1996

Volltextzugriff (PDF)

Total androgen suppression: experience from the Scandinavian Prostatic Cancer Group Study No. 2

European urology, 1993-01, Vol.24 (4), p.466-470

1993

Volltextzugriff (PDF)

Effects on the endocrine system of long‐term treatment with the non‐steroidal anti‐androgen Casodex in patients with benign prostatic hyperplasia

British Journal of Urology, 1995-03, Vol.75 (3), p.335-340

1995

Volltextzugriff (PDF)

The effect of bicalutamide on prostate histology

The Prostate, 2001-03, Vol.46 (4), p.275-280

2001

Volltextzugriff (PDF)

Metabolism of androgens in the seminal vesicles and the different lobes of the prostate in young mature rats

Journal of steroid biochemistry, 1985-04, Vol.22 (4), p.513-519

1985

Volltextzugriff (PDF)

Prognostic factors in patients with metastatic (stage D2) prostate cancer: experience from the Scandinavian Prostatic Cancer Group Study-2

The Journal of urology, 1997-07, Vol.158 (1), p.164-170

1997

Volltextzugriff (PDF)

Long-term evaluation of aortic valvotomy for congenital aortic stenosis

Annals of surgery, 1987-10, Vol.206 (4), p.496-503

1987

Volltextzugriff (PDF)

Calcified aortic sinotubular ridge: A source of coronary ostial stenosis or embolism

Journal of the American College of Cardiology, 1988-12, Vol.12 (6), p.1510-1514

1988

Volltextzugriff (PDF)

Synchronous bilateral primary germ cell tumors in patient receiving estrogen therapy

Urology (Ridgewood, N.J.), 1988, Vol.31 (1), p.70-76

1988

Volltextzugriff (PDF)

5-YEAR FOLLOWUP OF A RANDOMIZED PROSPECTIVE STUDY COMPARING MITOMYCIN C AND BACILLUS CALMETTE-GUERIN IN PATIENTS WITH SUPERFICIAL BLADDER CARCINOMA

The Journal of urology, 1999-04, Vol.161 (4), p.1124-1127

1999

Volltextzugriff (PDF)

Age dependent changes in androgen metabolism in the rat prostate

Journal of steroid biochemistry, 1985-01, Vol.22 (4), p.521-528

1985

Volltextzugriff (PDF)

A new dihydrotestosterone-forming index (DHT i)

Journal of steroid biochemistry, 1985-04, Vol.22 (4), p.529-532

1985

Volltextzugriff (PDF)

Complications of invasive, urodynamic examinations and prostate biopsies in patients with benign prostatic hyperplasia

Scandinavian journal of urology and nephrology. Supplement, 1995, Vol.172, p.95

1995

Volltextzugriff (PDF)

1 – 25 von 390

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(333)
Mit Volltextzugriff
(288)

Publikationsform

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A prospective, placebo-controlled study of the luteinizing hormone-releasing hormone agonist leuprolide as treatment for patients with benign prostatic hyperplasia

A prospective, placebo-controlled study of the antiandrogen Casodex as treatment for patients with benign prostatic hyperplasia

Pathologic Downstaging Is a Surrogate Marker for Efficacy and Increased Survival Following Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Urothelial Bladder Cancer

Safety, side effects and patient acceptance of the luteinizing hormone releasing hormone agonist leuprolide in treatment of benign prostatic hyperplasia

Effects of bicalutamide and leuprolide on prostate-specific antigen (PSA), acid phosphatase (ACP) and prostatic acid phosphatase (PAP) in men with benign prostatic hyperplasia (BPH)

Safety, side effects and patient acceptance of the antiandrogen Casodex in the treatment of benign prostatic hyperplasia

alpha-blockade in the treatment of symptomatic benign prostatic hyperplasia

Measuring the quality of life of patients with benign prostatic hyperplasia. Assessment of the usefulness of a new quality of life questionnaire specially adapted to benign prostatic hyperplasia patients

Treatment of benign prostatic hyperplasia : A pharmacoeconomic perspective

Histopathological grading and DNA ploidy as prognostic markers in metastatic prostatic cancer

Extent of disease based on initial bone scan: important prognostic predictor for patients with metastatic prostatic cancer. Experience from the Scandinavian Prostatic Cancer Group Study No. 2 (SPCG-2)

Patient recruitment to and cost of a prospective trial of medical treatment for benign prostatic hyperplasia

Effects on the endocrine system of long-term treatment with the luteinizing hormone-releasing hormone agonist leuprolide in patients with benign prostatic hyperplasia

Total androgen suppression: experience from the Scandinavian Prostatic Cancer Group Study No. 2

Effects on the endocrine system of long‐term treatment with the non‐steroidal anti‐androgen Casodex in patients with benign prostatic hyperplasia

The effect of bicalutamide on prostate histology

Metabolism of androgens in the seminal vesicles and the different lobes of the prostate in young mature rats

Prognostic factors in patients with metastatic (stage D2) prostate cancer: experience from the Scandinavian Prostatic Cancer Group Study-2

Long-term evaluation of aortic valvotomy for congenital aortic stenosis

Calcified aortic sinotubular ridge: A source of coronary ostial stenosis or embolism

Synchronous bilateral primary germ cell tumors in patient receiving estrogen therapy

5-YEAR FOLLOWUP OF A RANDOMIZED PROSPECTIVE STUDY COMPARING MITOMYCIN C AND BACILLUS CALMETTE-GUERIN IN PATIENTS WITH SUPERFICIAL BLADDER CARCINOMA

Age dependent changes in androgen metabolism in the rat prostate

A new dihydrotestosterone-forming index (DHT i)

Complications of invasive, urodynamic examinations and prostate biopsies in patients with benign prostatic hyperplasia

Suchergebnisse filtern